← Browse by Condition
Medical Condition

hematopoietic and lymphoid cell neoplasm

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 1
NCT05334069
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i...
View Trial →
NCT04984551 Phase 2
Recruiting

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Enrollment
312 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05641961
Recruiting

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Enrollment
30 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT03816345 Phase 1
Recruiting

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT01772771
Recruiting

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Enrollment
12,000 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04776941
Recruiting

Expressive Writing for the Management of Stress in Cancer Survivors

Enrollment
414 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT03425526 Phase 1
Recruiting

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Enrollment
16 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05101213 Phase 1
Recruiting

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Enrollment
30 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →